The clinical imperative of a complete biochemical response to immunosuppression in autoimmune hepatitis: Close is not good enough!

Hepatology. 2024 Mar 1;79(3):529-531. doi: 10.1097/HEP.0000000000000597. Epub 2023 Sep 18.

Authors

George Cholankeril^{1

2}, John M Vierling^{1

2}

Affiliations

¹ Section of Gastroenterology and Hepatology, Margaret M. and Albert B. Alkek Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
² Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.

PMID: 37722131
DOI: 10.1097/HEP.0000000000000597

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Hepatitis, Autoimmune* / drug therapy
Humans
Immunosuppression Therapy

Associated data

ClinicalTrials.gov/NCT03217422